OpenVSafe by OpenVAERS
Search V-safe

EJF-31161-63618

2 vaccinations 5 coded responses 25 check-ins 5 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
934 / CA
Registered
2021-01-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-20
    Dose 1 — Moderna
  2. 2021-01-21
    Registered in v-safe
  3. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-17
    Dose 2 — Moderna
  13. 2021-02-17
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  17. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-24
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  21. 2021-03-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-17
    Survey response — day 28, dose 2
    MedDRA: Bile duct stent insertion, Inflammation, Pancreatitis, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Gall bladder and pancreatitis. Had a stent put in my common bile duct to help with inflammation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-17
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-03-24
    Survey response — day 35, dose 2
    MedDRA: Gallbladder disorder, Hospitalisation — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Hospitalized again for gallbladder attack overnight.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-03-31
    Survey response — day 42, dose 2
    MedDRA: Biliary colic, Emergency care — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Another gall bladder attack that required an overnight from the ER.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-03-31
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-05-19
    Survey response — 3 months, dose 2
    MedDRA: Cholangiocarcinoma, Neoplasm, Pancreaticoduodenectomy — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Had a Whipple surgery to remove a tumor in my common billary Duct on April 19 Cholangiocarcinoma
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-05-19
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  30. 2021-08-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-12-28
  32. 2022-02-20
    Survey response — 12 months, dose 2
    MedDRA: Alanine aminotransferase increased, Aspartate aminotransferase increased, Carbohydrate antigen 19-9 increased, Carcinoembryonic antigen increased, Hepatic enzyme increased, Occult blood positive, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Rise in liver enzymes AGT/AST. Also in CEA and CA19 a month after booster. Back to normal in January. Positive FIT test · Healthcare visit (other): In person CT scan of chest abdomen thorax: colonoscopy
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-02-20
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  34. 2022-02-22
  35. 2022-02-22
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-01-20Moderna
22021-02-17Moderna

Call center

4 call center cases

4 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 28, dose 2

2021-03-17

Symptoms: Gall bladder and pancreatitis. Had a stent put in my common bile duct to help with inflammation.

Release 6 — day 35, dose 2

2021-03-24

Symptoms: Hospitalized again for gallbladder attack overnight.

Release 6 — day 42, dose 2

2021-03-31

Symptoms: Another gall bladder attack that required an overnight from the ER.

Release 8 — 3 months, dose 2

2021-05-19

Symptoms: Had a Whipple surgery to remove a tumor in my common billary Duct on April 19 Cholangiocarcinoma

Release 11 — 12 months, dose 2

2022-02-20

Symptoms: Rise in liver enzymes AGT/AST. Also in CEA and CA19 a month after booster. Back to normal in January. Positive FIT test
Healthcare visit (other): In person CT scan of chest abdomen thorax: colonoscopy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAlanine aminotransferase increased · · ✓
SDAspartate aminotransferase increased · · ✓
SDBile duct stent insertion ✓ · ○
SDBiliary colic ✓ ✓ ✓
SDCarbohydrate antigen 19-9 increased · · ✓
SDCarcinoembryonic antigen increased · · ✓
SDCholangiocarcinoma ✓ ✓ ✓
SDEmergency care ✓ ✓ ✓
SDGallbladder disorder ✓ ✓ ✓
SDHepatic enzyme increased · · ✓
SDHospitalisation ✓ ✓ ✓
SDInflammation ✓ · ✓
SDNeoplasm ✓ ✓ ✓
SDOccult blood positive · · ✓
SDPancreaticoduodenectomy ✓ ✓ ✓
SDPancreatitis ✓ ✓ ✓
SDUnevaluable event ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release